acute gi bleed - Nursing Case Study
Pathophysiology
• Primary mechanism: Disruption of the gastrointestinal mucosal lining, often caused by peptic ulcers, can lead to erosion into blood vessels, resulting in hemorrhage. This mucosal injury is frequently due to factors like NSAID use or H. pylori infection.
• Secondary mechanism: Variceal bleeding, particularly in patients with portal hypertension from liver cirrhosis, causes increased pressure in the portal venous system, leading to dilation and rupture of esophageal or gastric varices.
• Key complication: Hypovolemic shock may occur if bleeding is severe and rapid, leading to decreased perfusion to vital organs and requiring immediate intervention to restore hemodynamic stability.
Patient Profile
Demographics:
57-year-old male, construction worker
History:
• Key past medical history: Hypertension, peptic ulcer disease
• Current medications: Lisinopril 10 mg daily, Omeprazole 20 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Vomiting blood
• Key symptoms: Melena, dizziness, fatigue
• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air
Section 1
As the healthcare team initiates the initial assessment, the patient is found to be pale and diaphoretic, indicating significant blood loss. Physical examination reveals a distended abdomen with tenderness in the epigastric region. The patient reports worsening dizziness and an increase in fatigue, suggesting worsening hypovolemia. His heart rate has increased to 120 bpm, and his blood pressure has dropped further to 85/55 mmHg, pointing towards the development of hypovolemic shock. Auscultation of the lungs is unremarkable, but his oxygen saturation has decreased to 89% despite supplementary oxygen, hinting at compromised gas exchange potentially due to decreased perfusion.
Laboratory tests are expedited, revealing a hemoglobin level of 7.2 g/dL, significantly lower than normal, confirming acute blood loss anemia. His blood urea nitrogen (BUN) is elevated at 45 mg/dL, and creatinine is borderline high at 1.4 mg/dL, suggesting prerenal azotemia due to hypoperfusion of the kidneys. An urgent endoscopy is scheduled to identify the source of bleeding. In the meantime, intravenous fluids are administered aggressively to restore volume, and a blood transfusion is initiated to address the severe anemia.
Despite these interventions, the patient develops altered mental status, becoming increasingly lethargic and confused, indicating potential cerebral hypoperfusion. This new complication requires the healthcare team to swiftly reassess his hemodynamic status and consider additional interventions, such as more aggressive fluid resuscitation, vasopressor support, and close monitoring in a critical care setting. The evolving situation demands continuous reassessment and rapid adjustments to the management plan to stabilize the patient and prevent further deterioration.
Section 2
As the healthcare team continues to manage the patient's condition, the decision is made to administer vasopressor support due to the persistent hypotension despite aggressive fluid resuscitation. Norepinephrine is initiated to enhance vasoconstriction and improve blood pressure. This intervention results in a slight increase in blood pressure to 95/60 mmHg, though the heart rate remains elevated at 118 bpm. The patient's oxygen saturation improves slightly to 92% on high-flow oxygen, indicating a marginal improvement in perfusion, but the altered mental status persists, with the patient remaining lethargic and minimally responsive.
The urgent endoscopy reveals a large peptic ulcer in the duodenum with active bleeding, providing a clear source for the GI bleed. Endoscopic intervention is performed, including cauterization and clipping to control the hemorrhage. This direct intervention is crucial in stabilizing the source of bleeding, yet the patient's hemodynamic instability suggests ongoing challenges in maintaining effective circulation and organ perfusion.
Laboratory results reveal a slight improvement in hemoglobin to 8.1 g/dL following the blood transfusion, but the BUN remains elevated at 48 mg/dL, and creatinine has risen to 1.6 mg/dL, indicating worsening renal function. The team is now faced with the challenge of balancing volume resuscitation with the risk of fluid overload, especially in light of the compromised renal status. Continuous monitoring in a critical care setting is essential, with a focus on adjusting fluid management and evaluating for any signs of organ dysfunction. This phase of care highlights the need for ongoing clinical reasoning to anticipate and address potential complications in this complex, dynamic situation.
Section 3
As the critical care team continues to monitor the patient's condition, a new complication arises. Despite the initial stabilization achieved through endoscopic intervention and vasopressor support, the patient's respiratory status begins to deteriorate. The oxygen saturation, which had improved to 92% on high-flow oxygen, starts to decline, now reading at 88%. Breath sounds reveal coarse crackles bilaterally, suggesting the development of pulmonary edema, likely secondary to aggressive fluid resuscitation and compromised cardiac function.
A chest X-ray is ordered and confirms the presence of bilateral infiltrates consistent with pulmonary edema. This finding necessitates a reassessment of the fluid management strategy, particularly given the patient's worsening renal function. The team considers the potential benefit of diuretic therapy to mitigate fluid overload while carefully balancing the risk of further decreasing intravascular volume and worsening hypotension. The decision is made to initiate a low-dose infusion of furosemide, with plans for frequent reassessment of the patient's hemodynamic status and renal function.
Additionally, a repeat arterial blood gas analysis is performed and reveals a pH of 7.32, PaCO2 of 50 mmHg, and HCO3- of 24 mEq/L, indicating a mixed respiratory and metabolic acidosis. This complicates the clinical picture, emphasizing the need for meticulous titration of respiratory support and exploration of potential underlying causes, such as hypoperfusion-related lactic acidosis or respiratory muscle fatigue. The interdisciplinary team must now prioritize interventions that address both pulmonary and renal complications while maintaining adequate perfusion, all of which require careful, ongoing clinical reasoning and adjustments in the treatment plan.
Section 4
As the patient's condition evolves, the critical care team turns its attention to the patient's hemodynamic status, closely monitoring for any signs of instability. After the initiation of the low-dose furosemide infusion, there is a slight improvement in the patient's respiratory status, with oxygen saturation inching up to 90% on high-flow oxygen. However, the blood pressure remains a concern, with readings fluctuating around 85/55 mmHg despite ongoing vasopressor support. This suggests a delicate balance between managing fluid overload and maintaining adequate blood pressure, necessitating frequent adjustments to both the furosemide and vasopressor infusion rates.
In parallel, laboratory results reveal a worsening of renal function, with serum creatinine rising to 2.3 mg/dL from a previous 1.8 mg/dL, and blood urea nitrogen climbing to 45 mg/dL. These changes indicate acute kidney injury, likely exacerbated by both the initial hypotensive episodes and current diuretic therapy. The team contemplates the use of renal replacement therapy as a temporary measure to manage the fluid overload while protecting renal function. Meanwhile, they continue to evaluate the patient's acid-base status, keeping a close watch on the lactate levels, which show a slight elevation at 3.0 mmol/L, suggesting a component of lactic acidosis.
The team decides to implement a multifaceted approach, prioritizing interventions that address both the pulmonary and renal challenges. They adjust the ventilator settings to improve gas exchange and reduce the work of breathing, considering the potential for respiratory muscle fatigue. In concert with these adjustments, they initiate continuous renal replacement therapy (CRRT) to manage fluid overload without compromising hemodynamic stability. Throughout this process, the team engages in dynamic clinical reasoning, reassessing the patient's response to interventions and remaining vigilant for any new complications that may arise. This careful orchestration of care aims to stabilize the patient and create a pathway toward recovery.
Section 5
Following the initiation of continuous renal replacement therapy (CRRT), the patient's fluid balance begins to show signs of improvement, with a gradual decrease in peripheral edema and a reduction in daily fluid gains. However, over the next 12 hours, the patient exhibits a change in neurological status, becoming increasingly lethargic and unresponsive to verbal stimuli. The critical care team conducts a thorough neurological assessment, noting sluggish pupillary response and decreased motor response to painful stimuli, raising concerns about potential central nervous system involvement.
Concurrently, new laboratory results reveal an alarming drop in hemoglobin levels, now at 6.5 g/dL from the previous 8.0 g/dL, indicating ongoing gastrointestinal bleeding. The team prioritizes a repeat upper endoscopy to identify and address any active bleeding source, while also preparing for possible blood transfusions to stabilize hemoglobin levels and improve oxygen delivery. Additionally, a head CT scan is ordered to rule out any intracranial pathology that might explain the altered mental status.
These developments prompt the team to reassess the overall management strategy, considering the delicate balance required to address the patient's multiple, interrelated issues. They explore potential adjustments to the vasopressor regimen to optimize cerebral perfusion pressure and contemplate the introduction of neuroprotective measures, while simultaneously coordinating with gastroenterology for urgent intervention. This scenario challenges the team to integrate evolving clinical data and adapt their approach to navigate the complexities of managing acute GI bleed with emerging complications, striving to stabilize the patient and facilitate recovery.